Click here for more information about laboratory operations and procedures
Sjogren's Antibodies
| Item | Value | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Approval req'd? | No | ||||||||
| Available Stat? | No | ||||||||
| Test code | SSAB | ||||||||
| Performed by | Immunology | ||||||||
| In House Availability | Wednesday (day shift) | ||||||||
| Method | EIA | ||||||||
| Container type | Gold top | ||||||||
| Amount to Collect | 1 mL blood | ||||||||
| Sample type | Serum | ||||||||
| Preferred volume | 0.5 mL serum | ||||||||
| Processing notes | Freeze at -20C | ||||||||
| Units | Units | ||||||||
| Normal range | anti-SSA and anti-SSB:
|
||||||||
| Synonyms | anti-SSA; anti-SSB; anti-Ro; anti-La | ||||||||
| Turn around times | 2-9 days | ||||||||
| Additional information | Antibodies to SSA (Ro) are present in approximately 60-70% of patients with Sjogren's syndrome and 30-40% of patients with systemic lupus erythematosus (SLE). The presence of this autoantibody in pregnant women has been associated with development of neonatal congenital heart block and neonatal lupus. Antibodies to SSB (La) are found in approximately 60% of patients with Sjogren's syndrome and 11-24% of patients with SLE. Weak positive results may not have clinical significance. Clinical correlation is advised. Repeat testing may be considered, if clinically indicated. |
||||||||
| LOINC code | 33569-5 | ||||||||
| Last Updated | 1/30/2013 12:09:55 PM | ||||||||
| Entry Number | 857 |
If you have additional questions regarding this test, please call: 415-353-1667